Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 1
1981 1
1982 2
1983 1
1984 1
1985 1
1986 1
1987 1
1988 2
1989 2
1991 6
1992 2
1993 9
1994 3
1996 1
1997 4
1998 7
1999 3
2000 4
2001 4
2002 6
2003 6
2004 9
2005 8
2006 9
2007 6
2008 8
2009 13
2010 7
2011 13
2012 9
2013 7
2014 14
2015 14
2016 13
2017 13
2018 10
2019 17
2020 16
2021 18
2022 19
2023 20
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Results by year

Filters applied: . Clear all
Page 1
Parathyroid carcinoma.
Goswamy J, Lei M, Simo R. Goswamy J, et al. Curr Opin Otolaryngol Head Neck Surg. 2016 Apr;24(2):155-62. doi: 10.1097/MOO.0000000000000234. Curr Opin Otolaryngol Head Neck Surg. 2016. PMID: 26771263 Review.
PURPOSE OF REVIEW: This article highlights recent advances in our understanding of the incidence, epidemiology, clinical presentation, evaluation, diagnosis, treatment, and prognosis of parathyroid carcinoma. RECENT FINDINGS: The prevalence of parathyroid …
PURPOSE OF REVIEW: This article highlights recent advances in our understanding of the incidence, epidemiology, clinical presentation, evalu …
Advances in Endocrine Surgery.
Lui MS, Shirali AS, Huang BL, Fisher SB, Perrier ND. Lui MS, et al. Surg Oncol Clin N Am. 2023 Jan;32(1):199-220. doi: 10.1016/j.soc.2022.08.004. Epub 2022 Nov 3. Surg Oncol Clin N Am. 2023. PMID: 36410918 Review.
Surgery for primary hyperparathyroidism.
das Neves MC, Santos RO, Ohe MN. das Neves MC, et al. Arch Endocrinol Metab. 2022 Nov 11;66(5):678-688. doi: 10.20945/2359-3997000000557. Arch Endocrinol Metab. 2022. PMID: 36382757 Free PMC article. Review.
This manuscript also explores other conditions that warrant special consideration during surgical treatment for PHPT: normocalcemic primary hyperparathyroidism, pregnancy, reoperation for persistent or recurrent PHPT, parathyroid carcinoma, and familial and genetic …
This manuscript also explores other conditions that warrant special consideration during surgical treatment for PHPT: normocalcemic primary …
Parathyroid carcinoma: Current management and outcomes - A systematic review.
McInerney NJ, Moran T, O'Duffy F. McInerney NJ, et al. Am J Otolaryngol. 2023 Jul-Aug;44(4):103843. doi: 10.1016/j.amjoto.2023.103843. Epub 2023 Mar 23. Am J Otolaryngol. 2023. PMID: 36989753 Free article. Review.
OBJECTIVE: Parathyroid carcinoma is rarely encountered in clinical practice. When faced with this clinical challenge, there is currently a paucity of evidence available for the optimal management of patients with parathyroid carcinoma. ...METHODS: A sy …
OBJECTIVE: Parathyroid carcinoma is rarely encountered in clinical practice. When faced with this clinical challenge, there is …
In-depth proteomic signature of parathyroid carcinoma.
Kong SH, Lee JH, Bae JM, Hong N, Kim H, Park SY, Choi YJ, Lee S, Rhee Y, Kim SW, Han D, Kim JH, Shin CS. Kong SH, et al. Eur J Endocrinol. 2023 Apr 5;188(4):385-394. doi: 10.1093/ejendo/lvad046. Eur J Endocrinol. 2023. PMID: 36995894
OBJECTIVE: Diagnosing parathyroid carcinoma (PC) is complicated and controversial that early diagnosis and intervention are often difficult. ...
OBJECTIVE: Diagnosing parathyroid carcinoma (PC) is complicated and controversial that early diagnosis and intervention are of …
Approach to the Patient With Parathyroid Carcinoma.
Cetani F, Pardi E, Torregrossa L, Borsari S, Pierotti L, Dinoi E, Marcocci C. Cetani F, et al. J Clin Endocrinol Metab. 2023 Dec 21;109(1):256-268. doi: 10.1210/clinem/dgad455. J Clin Endocrinol Metab. 2023. PMID: 37531615
Parathyroid carcinoma (PC) is usually associated with severe symptomatic primary hyperparathyroidism (PHPT) and accounts for less than 1% of all cases of PHPT and approximately 0.005% of all cancers. ...
Parathyroid carcinoma (PC) is usually associated with severe symptomatic primary hyperparathyroidism (PHPT) and accounts for l …
Parathyroid carcinoma: Single centre experience.
Cunha C, Pinheiro SL, Donato S, Tavares Bello C, Simões H, Nunes Silva T, Prazeres S, Doutel D, Cavaco BM, Leite V. Cunha C, et al. Clin Endocrinol (Oxf). 2022 Sep;97(3):250-257. doi: 10.1111/cen.14684. Epub 2022 Feb 9. Clin Endocrinol (Oxf). 2022. PMID: 35120263
OBJECTIVE: Parathyroid Carcinoma is a rare malignant neoplasm, accounting for less than 1% of primary hyperparathyroidism cases. ...CDC73 mutations were present in 38.5% of analysed patients and one patient was diagnosed with MEN1. CONCLUSION: Parathyroid …
OBJECTIVE: Parathyroid Carcinoma is a rare malignant neoplasm, accounting for less than 1% of primary hyperparathyroidism case …
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling.
Teleanu MV, Fuss CT, Paramasivam N, Pirmann S, Mock A, Terkamp C, Kircher S, Landwehr LS, Lenschow C, Schlegel N, Stenzinger A, Jahn A, Fassnacht M, Glimm H, Hübschmann D, Fröhling S, Kroiss M. Teleanu MV, et al. Mol Oncol. 2023 Jul;17(7):1343-1355. doi: 10.1002/1878-0261.13398. Epub 2023 Apr 11. Mol Oncol. 2023. PMID: 36808802 Free PMC article.
Parathyroid carcinoma (PC) is an ultra-rare malignancy with a high risk of recurrence after surgery. ...
Parathyroid carcinoma (PC) is an ultra-rare malignancy with a high risk of recurrence after surgery. ...
Parathyroid carcinoma: Challenges in diagnosis and treatment.
Betea D, Potorac I, Beckers A. Betea D, et al. Ann Endocrinol (Paris). 2015 May;76(2):169-77. doi: 10.1016/j.ando.2015.03.003. Epub 2015 Apr 21. Ann Endocrinol (Paris). 2015. PMID: 25910997 Review.
Parathyroid carcinoma is a malignant neoplasm affecting 0.5 to 5.0% of all patients suffering from primary hyperparathyroidism. ...The third/second generation PTH assay ratio provides valuable information to distinguish between benign parathyroid disease and para …
Parathyroid carcinoma is a malignant neoplasm affecting 0.5 to 5.0% of all patients suffering from primary hyperparathyroidism …
Parathyroid carcinoma: etiology, diagnosis, and treatment.
Okamoto T, Iihara M, Obara T, Tsukada T. Okamoto T, et al. World J Surg. 2009 Nov;33(11):2343-54. doi: 10.1007/s00268-009-9999-0. World J Surg. 2009. PMID: 19350316 Review.
BACKGROUND: The goal of the present study was to make our medical practice evidence-based for patients with parathyroid carcinoma. METHODS: We posed six clinical questions relevant to the management of parathyroid cancer. ...Mutations in HRPT2, the gene responsible …
BACKGROUND: The goal of the present study was to make our medical practice evidence-based for patients with parathyroid carcinoma …
285 results